- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05740865
Risk Factors Associated With Infection After Spine Surgery
April 2, 2023 updated by: Xuanwu Hospital, Beijing
Predicting Deep Surgical Site Infection in Patients Receiving Open Posterior Instrumented Thoracolumbar Surgery--- A-DOUBLE-SSI Risk Score: a Large Retrospective Multicenter Cohort Study in China
Surgical site infection (SSI), particularly deep SSI, is one of the most serious complications after spinal surgery.
evaluating the risk of SSI and, correspondingly, prescription of prophylactic measures are extremely important to prevent SSI and avoid potentially devastating consequences.
A retrospective study was conducted aiming to develop a point-based prediction model of deep surgical site infection in patients receiving open posterior instrumented thoracolumbar surgery.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Data of 3,419 patients in 4 hospitals from Jan 1, 2012 to Dec 30, 2021 were retrospectively collected and were evaluated aiming to develop a point-based prediction model of deep surgical site infection in patients receiving open posterior instrumented thoracolumbar surgery.
Clinical knowledge-driven, data-driven and decision tree model was used to identify predictive variables of deep SSI.
Internal validation was performed by using bootstrapping methods.
Study Type
Observational
Enrollment (Actual)
3419
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Beijing, China, 100053
- Xuanwu Hospital, China International Neuroscience Institute, Capital Medical University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Study population included patients who previously receceived open posterior instrumented thoracolumbar surgery due to spine disease (except that spine infection or revision surgery)
Description
Inclusion Criteria:
patients who previously received open posterior instrumented thoracolumbar surgery
Exclusion Criteria:
- were aged < 18 years;
- underwent surgery for the spinal infection, spine revision surgery, or cervical operation;
- were diagnosed as superficial SSI;
- died in hospital;
- diagnosis of SSI was not determined;
- had missing data more than 10% were excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
patients who developed deep surgical site infection after thoracolumbar surgery
this group included patients who developed deep surgical site infection after open posterior instrumented thoracolumbar surgery
|
Both group previously received open posterior instrumented thoracolumbar surgery in 4 centers
|
|
patients who did not develop deep surgical site infection after thoracolumbar surgery
this group included patients who did not develop deep surgical site infection after open posterior instrumented thoracolumbar surgery
|
Both group previously received open posterior instrumented thoracolumbar surgery in 4 centers
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
deep surgical site infection
Time Frame: within 30 days after the operation
|
deep SSI was defined as an infection occurring within 30 days after the operation involving deep soft tissues along with one of the following criterion: (1)purulent drainage from the deep incision but not from the organ/space component of the surgical site;(2) a deep incision spontaneously dehisces or is deliberately opened by a surgeon when the patient has at least one of the following signs or symptoms: fever >38℃, localized pain, or tenderness, unless site is culture-negative;(3) an abscess or other evidence of infection involving the deep incision is found on direct examination, during reoperation, or by histopathologic or radiologic examination;(4) diagnosis of a deep incisional SSI by a surgeon or attending physician.
In this study, organ space SSI was also classified as deep SSI due to the same criteria as deep SSI.
|
within 30 days after the operation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Fengzeng Jian, Xuanwu Hospital, China International Neuroscience Institute, Capital Medical University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2012
Primary Completion (Actual)
December 31, 2021
Study Completion (Actual)
January 20, 2023
Study Registration Dates
First Submitted
February 13, 2023
First Submitted That Met QC Criteria
February 13, 2023
First Posted (Actual)
February 23, 2023
Study Record Updates
Last Update Posted (Actual)
April 4, 2023
Last Update Submitted That Met QC Criteria
April 2, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Neurospine_infection
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spine Surgery
-
University of California, San FranciscoRecruitingPain | Spine | Spine Surgery | Spine Fusion | Spine Surgery With Neuromonitoring | Spine Surgery With Motor Evoked Potential MonitoringUnited States
-
Rothman Institute OrthopaedicsEnrolling by invitation
-
Surgify Medical OyCompletedSurgery | Spine SurgeryFinland
-
King Khalid University HospitalNot yet recruitingSpine SurgerySaudi Arabia
-
Advanced Scanners Inc.Enrolling by invitation
-
GCS Ramsay Santé pour l'Enseignement et la RechercheTerminated
-
Brigham and Women's HospitalCompleted
-
Albany Medical CollegeUnknown
-
Shahid Beheshti UniversityCompletedSpine SurgeryIran, Islamic Republic of
-
University of California, San FranciscoTerminated
Clinical Trials on open posterior instrumented thoracolumbar surgery
-
Canadian Memorial Chiropractic CollegeCompleted
-
AO Foundation, AO SpineRecruitingSpinal FusionUnited States, Japan, Spain, Canada, China, India, Turkey (Türkiye)
-
Rothman Institute OrthopaedicsUnknown
-
National Taiwan University HospitalNot yet recruitingthe GERD Occurence
-
Nanfang Hospital, Southern Medical UniversityRecruiting
-
Peking University Third HospitalSecond Affiliated Hospital, School of Medicine, Zhejiang University; Second... and other collaboratorsNot yet recruitingAtlantoaxial DislocationChina
-
Hawler Medical UniversityCompleted
-
Gazi UniversityCompletedSpinal Deformity | Hemothorax PostoperativeTurkey
-
Shoichi Fujii, MD, PhDUnknownColorectal CancerJapan
-
Xijing HospitalRecruitingCervical Spinal Stenosis | Posterior Cervical Spine Surgery | Barbed SutureChina